Electric field device shows promise for tough brain tumors
NCT ID NCT03450850
First seen Feb 18, 2026 · Last updated May 23, 2026 · Updated 12 times
Summary
This study tested a wearable device called NOVOTTF-200A in adults with recurrent Grade III anaplastic astrocytoma, a type of brain cancer. The goal was to see if the device could stop tumor growth for at least six months. Only one person enrolled, and the study looked at safety and how well the device worked.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTROCYTOMA, GRADE III are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, Irvine
Orange, California, 92868, United States
Conditions
Explore the condition pages connected to this study.